Kazutaka Oda, Shinichiro Okamoto, Eisaku Iwanaga, Hirotomo Nakata. Investigating the WHO's AWaRe classification for assessing antimicrobial stewardship programs: A single-center study. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2024
Tomofumi Nakamura, Tatsuya Yoshinouchi, Mayu Okumura, Toshiro Yokoyama, Daisuke Mori, Hirotomo Nakata, Jun-ichirou Yasunaga, Yasuhito Tanaka. Antifungal potency of terbinafine as a therapeutic agent against Exophiala dermatitidis in vitro. 2024
Tomofumi Nakamura, Mitsuhiro Uchiba, Hirotomo Nakata, Takao Mizumoto, Toru Beppu, Shuzo Matsushita. Partial Splenic Embolization in a Patient with Hemophilia A and Severe Thrombocytopenia: A Case Report. Hematology Reports. 2024. 16. 2. 185-192
Tomofumi Nakamura, Mayu Okumura, Nobutoki Takamune, Tatsunori Hirotsu, Masaharu Sugiura, Junichiro Yasunaga, Hirotomo Nakata. Conversion of raltegravir carrying a 1,3,4-oxadiazole ring to a hydrolysis product upon pH changes decreases its antiviral activity. PNAS nexus. 2024. 3. 1. pgad446
Kazutaka Oda, Ayami Yamaguchi, Naoya Matsumoto, Hirotomo Nakata, Yusuke Higuchi, Kisato Nosaka, Hirofumi Jono, Hideyuki Saito. Dose Individualization of Cefepime for Febrile Neutropenia in Patients With Lymphoma or Multiple Myeloma: Implications for Therapeutic Drug Monitoring. Therapeutic drug monitoring. 2023. 46. 1. 80-88